|
|
||||||||
Department of Pediatrics, Childrens Hospital Medical Center, Cincinnati, Ohio
Address reprint requests to: Kenneth D. R. Setchell, PhD, Professor of Pediatrics, Director, Clinical Mass Spectrometry, Childrens Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, Ohio 45229. Email: SETCK0{at}CHMCC.ORG
Phytoestrogens have become one of the more topical areas of interest in clinical nutrition. These non-nutrient bioactive compounds are ubiquitous to the plant kingdom and possess a wide range of biological properties that contribute to the many different health-related benefits reported for soy foods and flaxseedstwo of the most abundant dietary sources of phytoestrogens. Reviewed is the recent knowledge related to their pharmacokinetics and clinical effects, focusing mainly on isoflavones that are found in high concentrations in soy foods. Arguments are made for considering soy isoflavones as natural selective estrogen receptor modulators (SERMs) based upon recent data of their conformational binding to estrogen receptors. Rebuttal is made to several key and important issues related to the recent concerns about the safety of soy and its constituent isoflavones. This article is not intended to be a comprehensive review of the literature but merely highlight recent research with key historical perspectives.
Key words: soy isoflavones, phytoestrogens, pharmacokinetics, phytoprotectants
This article has been cited by other articles:
![]() |
C. Duffy, K. Perez, and A. Partridge Implications of Phytoestrogen Intake for Breast Cancer CA Cancer J Clin, September 1, 2007; 57(5): 260 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cupisti, L. Ghiadoni, C. D'Alessandro, I. Kardasz, E. Morelli, V. Panichi, D. Locati, S. Morandi, A. Saba, G. Barsotti, et al. Soy protein diet improves endothelial dysfunction in renal transplant patients Nephrol. Dial. Transplant., January 1, 2007; 22(1): 229 - 234. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Atkinson, J. W Lampe, D. Scholes, C. Chen, K. Wahala, and S. M Schwartz Lignan and isoflavone excretion in relation to uterine fibroids: a case-control study of young to middle-aged women in the United States. Am. J. Clinical Nutrition, September 1, 2006; 84(3): 587 - 593. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A Ryan-Borchers, J. S. Park, B. P Chew, M. K McGuire, L. R Fournier, and K. A Beerman Soy isoflavones modulate immune function in healthy postmenopausal women Am. J. Clinical Nutrition, May 1, 2006; 83(5): 1118 - 1125. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Olson, M. E. Kargacin, T. W. Honeyman, C. A. Ward, and G. J. Kargacin Effects of Phytoestrogens on Sarcoplasmic/Endoplasmic Reticulum Calcium ATPase 2a and Ca2+ Uptake into Cardiac Sarcoplasmic Reticulum J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 628 - 635. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. F Adams, P. D Lampe, K. M Newton, J T. Ylvisaker, A. Feld, D. Myerson, S. S Emerson, E. White, J. D Potter, and J. W Lampe Soy protein containing isoflavones does not decrease colorectal epithelial cell proliferation in a randomized controlled trial Am. J. Clinical Nutrition, September 1, 2005; 82(3): 620 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Schreihofer, K. D. Do, and A. M. Schreihofer High-soy diet decreases infarct size after permanent middle cerebral artery occlusion in female rats Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2005; 289(1): R103 - R108. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zhan and S. C Ho Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile Am. J. Clinical Nutrition, February 1, 2005; 81(2): 397 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Selvaraj, M. A. Zakroczymski, A. Naaz, M. Mukai, Y. H. Ju, D. R. Doerge, J. A. Katzenellenbogen, W. G. Helferich, and P. S. Cooke Estrogenicity of the Isoflavone Metabolite Equol on Reproductive and Non-Reproductive Organs in Mice Biol Reprod, September 1, 2004; 71(3): 966 - 972. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Merritt and B. H. Jenks Safety of Soy-Based Infant Formulas Containing Isoflavones: The Clinical Evidence J. Nutr., May 1, 2004; 134(5): 1220S - 1224S. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. F. Adams, C. Chen, K. M. Newton, J. D. Potter, and J. W. Lampe Soy Isoflavones Do Not Modulate Prostate-Specific Antigen Concentrations in Older Men in a Randomized Controlled Trial Cancer Epidemiol. Biomarkers Prev., April 1, 2004; 13(4): 644 - 648. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Blum, S. N. Heaton, B. M. Bowman, M. Hegsted, and S. C. Miller Dietary Soy Protein Maintains Some Indices of Bone Mineral Density and Bone Formation in Aged Ovariectomized Rats J. Nutr., May 1, 2003; 133(5): 1244 - 1249. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. F. Adams, K. M. Newton, C. Chen, S. S. Emerson, J. D. Potter, E. White, and J. W. Lampe Soy Isoflavones Do Not Modulate Circulating Insulin-Like Growth Factor Concentrations in an Older Population in an Intervention Trial J. Nutr., May 1, 2003; 133(5): 1316 - 1319. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. R. Setchell, N. M. Brown, and E. Lydeking-Olsen The Clinical Importance of the Metabolite Equol--A Clue to the Effectiveness of Soy and Its Isoflavones J. Nutr., December 1, 2002; 132(12): 3577 - 3584. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Khalil, E. A. Lucas, S. Juma, B. J. Smith, M. E. Payton, and B. H. Arjmandi Soy Protein Supplementation Increases Serum Insulin-Like Growth Factor-I in Young and Old Men but Does Not Affect Markers of Bone Metabolism J. Nutr., September 1, 2002; 132(9): 2605 - 2608. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Badger, M. J. J. Ronis, R. Hakkak, J. C. Rowlands, and S. Korourian The Health Consequences of Early Soy Consumption J. Nutr., March 1, 2002; 132(3): 559S - 565. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |